Speciality: Pediatrics
Description:
A warm welcome to all the medical professionals in this interesting session of pediatric growth updates. We have Dr Kiran Meena, Dr Vaishakhi Rustagi, Dr Hemchand K Prasad, to lead the session.
Growth is a systematic process accompanied by several intrinsic and extrinsic factors. The physiological process involves several mechanisms and pathways.
In this webinar, you are going to get knowledge on WHO updates on growth, the growth charts which are pediatrician friendly. You will get immense knowledge on the factors that contribute to proper growth of the children.
Thus, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
See More Webinars @ Hidoc Webinars
1.
Oleanolic acid from grapes may increase chemotherapy effectiveness
2.
Daily physical activity, even at light intensities, linked to lower cancer risk
3.
AMA President-Elect Confronts a New Challenge: A Brain Tumor
4.
Treatment of Smoldering Myeloma Cuts Progression Rate in Half
5.
Virtual Reality Travel Reduces Cancer Pain.
1.
Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care
2.
Mitoxantrone–Napabucasin Co-Nanoformulation Activates cGAS-STING in HCC Therapy
3.
Understanding Protein C Deficiency: Symptoms, Causes, and Treatment
4.
Deterministic Reprogramming of Neutrophils within Tumors: A New Frontier in Cancer Research
5.
Next-Gen CAR Cell Therapies in Oncology: Frontiers in Solid Tumors & Hematologic Malignancies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A New Era in Managing Cancer-Associated Thrombosis
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
4.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
5.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation